Journal article
The gastrointestinal tolerability and safety of oral bisphosphonates
Abstract
Oral bisphosphonates are effective for osteoporosis and other hyperresorptive bone disorders. Although well-tolerated in efficacy trials, some oral aminobisphosphonates have been associated with upper gastrointestinal intolerance and injury in postmarketing experience. Clinical trials often underestimate the rate of adverse events in clinical practice, and ethics prohibit direct evaluation of toxicity in high-risk patients. Accordingly, animal …
Authors
Marshall JK
Journal
Expert Opinion on Drug Safety, Vol. 1, No. 1, pp. 71–78
Publisher
Taylor & Francis
Publication Date
May 2002
DOI
10.1517/14740338.1.1.71
ISSN
1474-0338